ES2139588T3 - Derivado de ciclopropano. - Google Patents

Derivado de ciclopropano.

Info

Publication number
ES2139588T3
ES2139588T3 ES92301802T ES92301802T ES2139588T3 ES 2139588 T3 ES2139588 T3 ES 2139588T3 ES 92301802 T ES92301802 T ES 92301802T ES 92301802 T ES92301802 T ES 92301802T ES 2139588 T3 ES2139588 T3 ES 2139588T3
Authority
ES
Spain
Prior art keywords
derivative
cyclopropane
elevated
independently
cyclopropanic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92301802T
Other languages
English (en)
Inventor
Satoshi Hatsuya
Takaaki Sekiyama
Takashi Tsuji
Satoshi Iwayama
Masahiko Okunishi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ajinomoto Co Inc
Original Assignee
Ajinomoto Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ajinomoto Co Inc filed Critical Ajinomoto Co Inc
Application granted granted Critical
Publication of ES2139588T3 publication Critical patent/ES2139588T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/18—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

UN DERIVADO CICLOPROPANO DE LA FORMULA (I) EN LA QUE B ELEVADO 1 ES UN RESIDUO DE PURINA O PIRIMIDINA, R ELEVADO 1 Y R (AL CUADRADO) SON, INDEPENDIENTEMENTE, HIDROGENO O UN GRUPO PROTECTOR PARA EL HIDROXIL Y CADA UNO DE K, M Y N REPRESENTA, INDEPENDIENTEMENTE, UN ENTERO DE 1 A 2, QUE ES UTIL POR SU EFECTO ANTIVIRAL.
ES92301802T 1991-03-05 1992-03-03 Derivado de ciclopropano. Expired - Lifetime ES2139588T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP12323991 1991-03-05
JP18470991 1991-07-24

Publications (1)

Publication Number Publication Date
ES2139588T3 true ES2139588T3 (es) 2000-02-16

Family

ID=26460224

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92301802T Expired - Lifetime ES2139588T3 (es) 1991-03-05 1992-03-03 Derivado de ciclopropano.

Country Status (9)

Country Link
US (2) US5342840A (es)
EP (1) EP0502690B1 (es)
JP (1) JP2923933B2 (es)
KR (1) KR100232619B1 (es)
AT (1) ATE187173T1 (es)
CA (1) CA2062299C (es)
DE (1) DE69230349T2 (es)
DK (1) DK0502690T3 (es)
ES (1) ES2139588T3 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR950011530A (ko) * 1993-10-21 1995-05-15 도바 다다스 사이클로프로판 유도체 및 이를 함유하는 항바이러스제
TW282470B (es) * 1993-11-18 1996-08-01 Ajinomoto Kk
JP3769737B2 (ja) * 1994-03-30 2006-04-26 味の素株式会社 シクロプロパン誘導体及びその製造法
EP0845454A1 (en) * 1996-12-02 1998-06-03 Ajinomoto Co., Inc. Method for the production of optically active cyclopropane derivatives
JPH1129572A (ja) * 1997-07-10 1999-02-02 Ajinomoto Co Inc 核酸誘導体の精製法
JPH11255768A (ja) 1998-03-09 1999-09-21 Ajinomoto Co Inc 抗ウイルス剤の製造方法
MY141789A (en) * 2001-01-19 2010-06-30 Lg Chem Investment Ltd Novel acyclic nucleoside phosphonate derivatives, salts thereof and process for the preparation of the same.
AU2002343604C1 (en) 2001-10-30 2009-09-17 Conforma Therapeutics Corporation Purine analogs having HSP90-inhibiting activity
JP2004026695A (ja) * 2002-06-24 2004-01-29 M's Science Corp 水性点眼用製剤
US7138401B2 (en) 2003-09-18 2006-11-21 Conforma Therapeutics Corporation 2-aminopurine analogs having HSP90-inhibiting activity
FR2864901B1 (fr) * 2004-01-09 2007-10-05 Philippe Perovitch Composition pour le traitement au contact des hyposialies, incluant de la pilocarpine et a effets multiples
AU2006230447A1 (en) 2005-03-30 2006-10-05 Conforma Therapeutics Corporation Alkynyl pyrrolopyrimidines and related analogs as HSP90-inhibitors
DE102005053153B4 (de) * 2005-11-04 2007-07-19 Helmut Ristl Ristl-Getriebe
GB0814065D0 (en) * 2008-08-01 2008-09-10 Univ Leuven Kath Use of nucleoside analogs as anti-koi herpes virus molecules
EP2768799B1 (en) 2011-10-17 2019-08-07 Biotheryx Inc. Substituted biaryl alkyl amides
CN107722009B (zh) * 2011-11-10 2020-12-01 阿拉塔纳医疗股份有限公司 用于制备环丙烷衍生物的方法
MX354990B (es) 2012-01-20 2018-03-28 Aratana Therapeutics Nv Composicion de gotas para los ojos.
CN104447749B (zh) * 2014-11-21 2016-06-01 河南师范大学 一种通过嘌呤对乙烯基环丙烷的选择性开环构建非环核苷的方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3923792A (en) * 1974-06-19 1975-12-02 Hoffmann La Roche Sulfacytosine derivatives
US4016267A (en) * 1974-06-19 1977-04-05 Hoffmann-La Roche Inc. Sulfacytosine derivatives
US4065480A (en) * 1975-06-12 1977-12-27 The Procter & Gamble Company Process for preparing substituted cyclopropycarbinyl compounds
CA1150299A (en) * 1978-08-17 1983-07-19 Pieter A. Verbrugge Intermediates in the preparation of cyclopropane-carboxylate esters and process for their manufacture
SE7810947L (sv) * 1978-10-20 1980-04-21 Draco Ab 3-alkylxanthines
US4617304A (en) * 1984-04-10 1986-10-14 Merck & Co., Inc. Purine derivatives
US4859680A (en) * 1984-04-10 1989-08-22 Merck & Co., Inc. Pyrimidine derivatives as antiviral compounds
US4714777A (en) * 1984-06-21 1987-12-22 University Of Pittsburgh Cyclopropanone hydrate derivatives
US4782062A (en) * 1987-05-11 1988-11-01 Merck & Co., Inc. 9-(2-hydroxymethyl)cycloalkylmethyl) guanines
EP0308896B1 (en) * 1987-09-24 1992-03-18 Mitsubishi Kasei Corporation Method for producing a cycloalkanol
US5126345A (en) * 1988-03-30 1992-06-30 E. R. Squibb & Sons, Inc. Bis (hydroxymethyl) cyclobutyl triazolopyrimidines
DE3824432A1 (de) * 1988-07-19 1990-03-22 Bayer Ag 2,2-difluorcyclopropyl-derivate
US5208388A (en) * 1988-07-19 1993-05-04 Bayer Aktiengesellschaft 2,2-difluorocyclopropyl derivatives
US4918075A (en) * 1988-12-20 1990-04-17 E. R. Squibb & Sons, Inc. Purinyl and pyrimidinyl cyclobutanes and their use as antiviral agents
US4988703A (en) * 1989-05-22 1991-01-29 Abbott Laboratories Carbocyclic nucleoside analogs with antiviral activity
US5064961A (en) * 1989-12-18 1991-11-12 E. R. Squibb & Sons, Inc. Process for preparing an optically active cyclobutane nucleoside
US5095136A (en) * 1990-08-27 1992-03-10 E. R. Squibb & Sons, Inc. Method for preparing isoprenoid cyclopropane 1,1-dicarboxylates and derivatives thereof and novel intermediates
DE4222497A1 (de) * 1992-07-09 1994-01-13 Huels Chemische Werke Ag Verfahren zur Herstellung von chlorfreiem Cyclopropancarbonsäuremethylester

Also Published As

Publication number Publication date
CA2062299C (en) 1999-05-25
EP0502690A2 (en) 1992-09-09
ATE187173T1 (de) 1999-12-15
KR920018052A (ko) 1992-10-21
EP0502690A3 (en) 1992-12-09
CA2062299A1 (en) 1992-09-06
DE69230349T2 (de) 2000-07-27
KR100232619B1 (ko) 1999-12-01
JPH0578357A (ja) 1993-03-30
US5342840A (en) 1994-08-30
JP2923933B2 (ja) 1999-07-26
DK0502690T3 (da) 2000-05-22
US5449840A (en) 1995-09-12
DE69230349D1 (de) 2000-01-05
EP0502690B1 (en) 1999-12-01

Similar Documents

Publication Publication Date Title
ES2139588T3 (es) Derivado de ciclopropano.
ES2160237T3 (es) O-carbamoil-fenilalaninol que tiene sustituyente en anillo de benceno, sus sales farmaceuticamente utiles, y metodo para la preparacion de los mismos.
ES2083464T3 (es) Compuestos heterociclicos.
ATE137125T1 (de) Verfahren und anlage für brandschutz
AR003937A1 (es) Compuesto ciclico que tiene efecto antagonico al receptor de taquiquinina, proceso para producirlo y composicion farmaceutica que lo contiene.
ES2033715T3 (es) Un procedimiento para producir un derivado de 2-fenoxipirimidina.
ES2121760T3 (es) Compuesto de pirazolopiridina y procedimiento para su preparacion.
ES2072779T3 (es) Derivados aminoacidos anfoteros.
ES2088574T3 (es) Derivado de anilida.
ES2062758T3 (es) Nuevos analogos de vitamina d.
ES2060547A1 (es) Mejoras en el objeto de la patente de invencion n/ 9201158 que se refiere a "procedimiento de obtencion de nuevos derivados de la 4-bencilpiperidina".
ES2057437T3 (es) Derivados de pirimidina, su produccion y su uso.
ES2062250T3 (es) Cicloalcano(b)-dihidroindol-e-indol sulfonamidas substituidas.
ES2030013T3 (es) Procedimiento para producir un nuevo compuesto que tiene base de hipoxantina.
AU530900B2 (en) Pressure sensitive marking paper
ES2070238T3 (es) Emulsion de lipidos que contiene un analogo de prostaglandina.
ES2056153T3 (es) Expectorante que comprende un derivado hidroxialquilcisteina.
ES2141471T3 (es) Derivados de calixarenos, su procedimiento de preparacion y utilizacion para la extraccion de actinidos y lantanidos.
ES2075004T3 (es) Derivados de pirimidina, procedimientos para su produccion y composiciones herbicidas que los contienen.
ES2052522T3 (es) Derivados de pirimidina, su preparacion y medicamentos que los contienen.
ES2059767T3 (es) Derivado de 1,4-dihidropiridina.
ES2088949T3 (es) Derivados de imidazolidina, su procedimiento de preparacion y pesticidas que los contienen.
ES8301209A1 (es) Un procedimiento para la preparacion de derivados de pirro- lidina
SE9501743L (sv) Färgmärkningsanordning i flerprocessmaskinens sågsvärd
ES462890A1 (es) Procedimiento para la preparacion de 1-(n-acil-carbamoil)-2-cianazi-ridinas con efecto cancerostatico y estimulador de inmunidad.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 502690

Country of ref document: ES